Stoke Therapeutics, Inc 10-K for FY2022
Stoke Therapeutics, Inc. (STOK)
10-K
2023-03-06
For: 2022-12-31
View Original
Added on
April 08, 2026
About this 10-K
Stoke Therapeutics, Inc filed this 10-K on March 6, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $12.41M
- Net loss
- $101.07M
- compared with a net loss of $85.81M a year earlier
- Diluted EPS
- -$2.60
- compared with -$2.34 a year earlier